Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group.
Bottomley A, Coens C, Suciu S, Santinami M, Kruit W, Testori A, Marsden J, Punt C, Salès F, Gore M, Mackie R, Kusic Z, Dummer R, Patel P, Schadendorf D, Spatz A, Keilholz U, Eggermont A. Bottomley A, et al. Among authors: kusic z. J Clin Oncol. 2009 Jun 20;27(18):2916-23. doi: 10.1200/JCO.2008.20.2069. Epub 2009 May 11. J Clin Oncol. 2009. PMID: 19433686 Clinical Trial.
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
Eggermont AM, Suciu S, Santinami M, Testori A, Kruit WH, Marsden J, Punt CJ, Salès F, Gore M, MacKie R, Kusic Z, Dummer R, Hauschild A, Musat E, Spatz A, Keilholz U; EORTC Melanoma Group. Eggermont AM, et al. Among authors: kusic z. Lancet. 2008 Jul 12;372(9633):117-126. doi: 10.1016/S0140-6736(08)61033-8. Lancet. 2008. PMID: 18620949 Free article. Clinical Trial.
Local interferon therapy for melanoma patients.
Ikić D, Spaventi S, Padovan I, Kusić Z, Cajkovac V, Ivanković D, Daković N, Nola P. Ikić D, et al. Among authors: kusic z. Int J Dermatol. 1995 Dec;34(12):872-4. doi: 10.1111/j.1365-4362.1995.tb04429.x. Int J Dermatol. 1995. PMID: 8647672
Local interferon therapy for lip carcinoma.
Ikić D, Padovan I, Pipić N, Daković N, Kusić Z. Ikić D, et al. Among authors: kusic z. Eur Arch Otorhinolaryngol. 1994;251(5):293-6. doi: 10.1007/BF00181888. Eur Arch Otorhinolaryngol. 1994. PMID: 7986501 Clinical Trial.
Interferon reduces recurrences of basal cell and squamous cell cancers.
Ikić D, Padovan I, Pipić N, Cajkovac V, Kusić Z, Daković N, Gregurek-Novak T, Soldo-Belić A, Spaventi S, Belicza M, et al. Ikić D, et al. Among authors: kusic z. Int J Dermatol. 1995 Jan;34(1):58-60. doi: 10.1111/j.1365-4362.1995.tb04382.x. Int J Dermatol. 1995. PMID: 7896491
[Interferon in the treatment of solid tumors].
Lukac J, Seso D, Daković N, Ferencić Z, Cajkovac V, Belicza M, Soos E, Ikić D, Kusić Z. Lukac J, et al. Among authors: kusic z. Lijec Vjesn. 1994 Nov-Dec;116(11-12):303-7. Lijec Vjesn. 1994. PMID: 7536287 Review. Croatian.
157 results